高级检索
当前位置: 首页 > 详情页

Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Medical Science Research Center, Zhongnan Hospital of Wuhan University, Wuhan 430071, China [2]Medical Research Institute, School of Medicine,Wuhan University, Wuhan 430071, China [3]Basic Medical School, Wuhan University, Wuhan 430060, China [4]Department of Cardiology, RenminHospital of Wuhan University, Wuhan 430060, China [5]Institute of Model Animals of Wuhan University, Wuhan 430060, China [6]Department ofGeneral Surgery, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China [7]College of Life Sciences, Hubei KeyLaboratory of Cell Homeostasis, Wuhan University, Wuhan 430072, China
出处:
ISSN:

关键词: CARD6 Hepatic ischemia/reperfusion ASK1

摘要:
Background & Aims: The hepatic injury caused by ischemia/reperfusion (I/R) insult is predominantly determined by the complex interplay of sterile inflammation and liver cell death. Caspase recruitment domain family member 6 (CARD6) was initially shown to play important roles in NF-kappa B activation. In our preliminary studies, CARD6 downregulation was closely related to hepatic I/R injury in liver transplantation patients and mouse models. Thus, we hypothesized that CARD6 protects against hepatic I/R injury and investigated the underlying molecular mechanisms. Methods: A partial hepatic I/R operation was performed in hepatocyte-specific Card6 knockout mice (HKO), Card6 transgenic mice with CARD6 overexpression specifically in hepatocytes (HTG), and the corresponding control mice. Hepatic histology, serum aminotransferases, inflammatory cytokines/chemokines, cell death, and inflammatory signaling were examined to assess liver damage. The molecular mechanisms of CARD6 function were explored in vivo and in vitro. Results: Liver injury was alleviated in Card6-HTG mice compared with control mice as shown by decreased cell death, lower serum aminotransferase levels, and reduced inflammation and infiltration, whereas Card6-HKO mice had the opposite phenotype. Mechanistically, phosphorylation of ASK1 and its downstream effectors JNK and p38 were increased in the livers of Card6-HKO mice but repressed in those of Card6-HTG mice. Furthermore, ASK1 knockdown normalized the effect of CARD6 deficiency on the activation of NF-kappa B, JNK and p38, while ASK1 overexpression abrogated the suppressive effect of CARD6. CARD6 was also shown to interact with ASK1. Mutant CARD6 that lacked the ability to interact with ASK1 could not inhibit ASK1 and failed to protect against hepatic I/R injury. Conclusions: CARD6 is a novel protective factor against hepatic I/R injury that suppresses inflammation and liver cell death by inhibiting the ASK1 signaling pathway. (C) 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 1 区 医学
小类 | 1 区 胃肠肝病学
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 胃肠肝病学
JCR分区:
出版当年[2016]版:
Q1 GASTROENTEROLOGY & HEPATOLOGY
最新[2023]版:
Q1 GASTROENTEROLOGY & HEPATOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Medical Science Research Center, Zhongnan Hospital of Wuhan University, Wuhan 430071, China [2]Medical Research Institute, School of Medicine,Wuhan University, Wuhan 430071, China [3]Basic Medical School, Wuhan University, Wuhan 430060, China [5]Institute of Model Animals of Wuhan University, Wuhan 430060, China
共同第一作者:
通讯作者:
通讯机构: [1]Medical Science Research Center, Zhongnan Hospital of Wuhan University, Wuhan 430071, China [3]Basic Medical School, Wuhan University, Wuhan 430060, China [4]Department of Cardiology, RenminHospital of Wuhan University, Wuhan 430060, China [5]Institute of Model Animals of Wuhan University, Wuhan 430060, China [7]College of Life Sciences, Hubei KeyLaboratory of Cell Homeostasis, Wuhan University, Wuhan 430072, China [*1]16 Luo-Jia-Shan Road, Wuhan 430072, China [*2]185 Donghu Road, Wuhan 430071, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21166 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)